Stromal-derived NRG1 enables oncogenic KRAS bypass in pancreas cancer

被引:0
|
作者
Han, Jincheng
Xu, Jiaqian
Liu, Yonghong
Liang, Shaoheng
LaBella, Kyle A.
Chakravarti, Deepavali
Spring, Denise J.
Xia, Yan
DePinho, Ronald A.
机构
关键词
D O I
10.1158/1538-7445.PANCA2023-IA20
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IA20
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Stromal-derived NRG1 enables oncogenic KRAS bypass in pancreas cancer
    Han, Jincheng
    Xu, Jiaqian
    Liu, Yonghong
    Liang, Shaoheng
    Labella, Kyle A.
    Chakravarti, Deepavali
    Spring, Denise J.
    Xia, Yan
    Depinho, Ronald A.
    GENES & DEVELOPMENT, 2023, 37 (17-18) : 818 - 828
  • [2] Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer
    Kapoor, Avnish
    Yao, Wantong
    Ying, Haoqiang
    Hua, Sujun
    Liewen, Alison
    Sadanandam, Anguraj
    Al-Khalil, Ramsey
    Viale, Andrea
    Pettazzoni, Piergiorgio
    Sanchez, Nora
    Protopopov, Alexei
    Zhang, Jianhua
    Heffernan, Timothy
    Johnson, Randy L.
    Chin, Lynda
    Wang, Y. Alan
    Draetta, Giulio
    DePinho, Ronald A.
    CANCER RESEARCH, 2015, 75
  • [3] Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer
    Kapoor, Avnish
    Yao, Wantong
    Ying, Haoqiang
    Hua, Sujun
    Liewen, Alison
    Wang, Qiuyun
    Zhong, Yi
    Wu, Chang-Jiun
    Sadanandam, Anguraj
    Hu, Baoli
    Chang, Qing
    Chu, Gerald
    Al-Khalil, Ramsey
    Jiang, Shan
    Xia, Hongai
    Fletcher-Sananikone, Eliot
    Lim, Carol
    Horwitz, Gillian
    Viale, Andrea
    Pettazzoni, Piergiorgio
    Sanchez, Nora
    Wang, Huamin
    Protopopov, Alexei
    Zhang, Jianhua
    Heffernan, Timothy
    Johnson, Randy
    Chin, Lynda
    Wang, Alan
    Draetta, Giulio
    DePinho, Ronald
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [4] Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
    Kapoor, Avnish
    Yao, Wantong
    Ying, Haoqiang
    Hua, Sujun
    Liewen, Alison
    Wang, Qiuyun
    Zhong, Yi
    Wu, Chang-Jiun
    Sadanandam, Anguraj
    Hu, Baoli
    Chang, Qing
    Chu, Gerald C.
    Al-Khalil, Ramsey
    Jiang, Shan
    Xia, Hongai
    Fletcher-Sananikone, Eliot
    Lim, Carol
    Horwitz, Gillian I.
    Viale, Andrea
    Pettazzoni, Piergiorgio
    Sanchez, Nora
    Wang, Huamin
    Protopopov, Alexei
    Zhang, Jianhua
    Heffernan, Timothy
    Johnson, Randy L.
    Chin, Lynda
    Wang, Y. Alan
    Draetta, Giulio
    DePinho, Ronald A.
    CELL, 2014, 158 (01) : 185 - 197
  • [5] NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
    Heining, Christoph
    Horak, Peter
    Uhrig, Sebastian
    Codo, Paula L.
    Klink, Barbara
    Hutter, Barbara
    Froehlich, Martina
    Bonekamp, David
    Richter, Daniela
    Steiger, Katja
    Penzel, Roland
    Endris, Volker
    Ehrenberg, Karl Roland
    Frank, Stephanie
    Kleinheinz, Kortine
    Toprak, Umut H.
    Schlesner, Matthias
    Mandal, Ranadip
    Schulz, Lothar
    Lambertz, Helmut
    Fetscher, Sebastian
    Bitzer, Michael
    Malek, Nisar P.
    Horger, Marius
    Giese, Nathalia A.
    Strobel, Oliver
    Hackert, Thilo
    Springfeld, Christoph
    Feuerbach, Lars
    Bergmann, Frank
    Schroeck, Evelin
    von Kalle, Christof
    Weichert, Wilko
    Scholl, Claudia
    Ball, Claudia R.
    Stenzinger, Albrecht
    Brors, Benedikt
    Froehling, Stefan
    Glimm, Hanno
    CANCER DISCOVERY, 2018, 8 (09) : 1087 - 1095
  • [6] Tumor Microenvironment Remodeling Enables Bypass of Oncogenic KRAS Dependency in Pancreatic Cancer
    Hou, Pingping
    Kapoor, Avnish
    Zhang, Qiang
    Li, Jiexi
    Wu, Chang-Jiun
    Li, Jun
    Lan, Zhengdao
    Tang, Ming
    Ma, Xingdi
    Ackroyd, Jeffrey J.
    Kalluri, Raghu
    Zhang, Jianhua
    Jiang, Shan
    Spring, Denise J.
    Wang, Y. Alan
    DePinho, Ronald A.
    CANCER DISCOVERY, 2020, 10 (07) : 1058 - 1077
  • [7] Oncogenic NRG1 Fusions: A New Hope for Targeted Therapy in Pancreatic Cancer
    Aguirre, Andrew J.
    CLINICAL CANCER RESEARCH, 2019, 25 (15) : 4589 - 4591
  • [8] KRAS mutation in colorectal cancer and its association with a stromal-derived gene signature.
    Pelossof, Raphael
    Elkabets, Moshe
    Chow, Oliver S.
    Fairchild, Lauren
    Chen, Chin-Tung
    Setty, Manu
    Smith, Jesse Joshua
    Dow, Lukas E.
    O'Rourke, Kevin P.
    Lowe, Scott W.
    Leslie, Christina S.
    Garcia-Aguilar, Julio
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [9] Oncogenic Neuregulin 1 gene (NRG1) fusions in cancer: A potential new therapeutic opportunities
    Zhang, Congwang
    Mei, Wuxuan
    Zeng, Changchun
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2022, 1877 (03):
  • [10] NRG1 fusions in breast cancer
    Karen D. Howarth
    Tashfina Mirza
    Susanna L. Cooke
    Suet-Feung Chin
    Jessica C. Pole
    Ernest Turro
    Matthew D. Eldridge
    Raquel Manzano Garcia
    Oscar M. Rueda
    Chris Boursnell
    Jean E. Abraham
    Carlos Caldas
    Paul A. W. Edwards
    Breast Cancer Research, 23